Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

MASAKA, Uganda—Every morning for the past four years, Agnes Mutesi, 30, has taken a pill that prevents her from getting ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

When you look at the numbers by race ... "At the time, I had full-blown AIDS, and now I have just HIV, thank God."His AIDS is undetectable now because of the care he’s been receiving. "I feel like ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on ...

I was widowed at 76, but I’m truly at my best when I’m coupled. I was at an art show at UCLA when I met the woman who became ...

"After a game, there would be 40 or 50 women waiting in the (hotel) lobby to meet us," Magic wrote, per the Chicago Tribune. ...